Alnylam Pharmaceuticals
ALNY
#591
Rank
โ‚น2.960 T
Marketcap
โ‚น22,956
Share price
-0.29%
Change (1 day)
62.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น234.45 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has โ‚น234.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น203.07 B11.94%
2022-12-31โ‚น181.42 B0.08%
2021-12-31โ‚น181.28 B32.24%
2020-12-31โ‚น137.08 B25.14%
2019-12-31โ‚น109.54 B44.51%
2018-12-31โ‚น75.80 B-29.77%
2017-12-31โ‚น107.94 B153.43%
2016-12-31โ‚น42.59 B-40.68%
2015-12-31โ‚น71.80 B62.62%
2014-12-31โ‚น44.15 B190.69%
2013-12-31โ‚น15.18 B125.89%
2012-12-31โ‚น6.72 B-13.17%
2011-12-31โ‚น7.74 B-25.86%
2010-12-31โ‚น10.44 B-19.99%
2009-12-31โ‚น13.05 B-36.88%
2008-12-31โ‚น20.68 B35.18%
2007-12-31โ‚น15.30 B59.04%
2006-12-31โ‚น9.62 B167.28%
2005-12-31โ‚น3.60 B80.53%
2004-12-31โ‚น1.99 B88.84%
2003-12-31โ‚น1.05 B42.28%
2002-12-31โ‚น0.74 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น36.63 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น826.12 B 252.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น123.15 B-47.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.42 B-98.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.96 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.182 T 404.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น614.26 B 162.00%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น190.41 B-18.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel